Both in R&D — Physical & Biological Sciences
iSpecimen vs bioAffinity Technologies
Over the past year ISPC returned −97.4% and BIAF returned −85.9%; their daily moves had a correlation of -0.04.
ISPC −97.4% BIAF −85.9%Growth of $1, one year, split-adjusted
| Metric | ISPC | BIAF |
|---|---|---|
| Price | $1.23 | $6.88 |
| Market cap | $3.1M | $4.1M |
| Today | +1.65% | −7.15% |
| 1 month | −20.1% | +41.3% |
| 6 months | −78.6% | −87.0% |
| Year to date | −88.2% | −61.1% |
| 1 year | −97.4% | −91.3% |
| Revenue growth (YoY) | −78.7% | +19.0% |
| Gross margin | 45.2% | 100.0% |
| Net margin | −896.9% | −222.8% |
| P/E (TTM) | — | — |
| Price / sales | 6.6× | 0.7× |
| Net cash | $4.4M | $1.8M |
| Dividend yield | — | — |
| Volatility (60d) | 97.3% | 823.5% |
| Short % of float | 14.5% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).